37th German Cancer Congress

Meet BIOTYPE on the 18th of February 2026 at the 37th German Cancer Congress (DKK) in Berlin!

Reliable detection of relevant molecular patterns in bladder cancer remains a challenge in many cases. This makes us even more pleased to present our current research‑related work at the German Cancer Congress 2026 in Berlin.

We will be showcasing two posters on molecular analyses in bladder carcinoma:

• 1062: “Evaluation of the MODAPLEX multiplex mRNA assay in muscle-invasive bladder cancer: comparison of responders and non-responders after neoadjuvant gemcitabine/cisplatin therapy”
• 1072: “Molecular profiling of therapy-associated targets in metastatic urothelial carcinoma using the MODAPLEX platform: a step toward precision oncology”

Our research focuses on:

• Comprehensive analysis of molecular expression patterns relevant to bladder cancer research
• Short turnaround times and a consolidated workflow that can replace multiple individual assays
• High analytical precision, even in challenging sample scenarios
• A deeper understanding of molecular heterogeneity within bladder cancer samples

These projects represent an early but important step toward better characterizing molecular patterns in bladder cancer and generating new avenues for future research and diagnostic exploration.

We look forward to engaging discussions.

On February 18, Vanessa Grunwald & Sabine Kießling‑Parr will be on site and are happy to connect around topics in molecular research, uro‑oncology, and translational science.

Let’s connect at DKK 2026 in Berlin!

‍